{"id":"W2275948481","doi":"10.1182/blood-2004-03-0796","title":"Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":407,"is_retracted":false,"has_abstract":true,"ca_institutions":"Kingston General Hospital","funders":"State University of New York Upstate Medical University; University of North Carolina at Chapel Hill; University of Illinois at Urbana-Champaign; Virginia Commonwealth University; McGill University; Syracuse University; University of Pittsburgh; Memorial Sloan-Kettering Cancer Center; Johns Hopkins University; University of Rochester; University of Miami; York University; University of Missouri; Georgetown University; National Cancer Institute; Wake Forest University; University of Pennsylvania; Dartmouth College; State University of New York; University of Nebraska Medical Center; Kaiser Permanente; University of South Carolina; University of Minnesota; Massachusetts General Hospital; University of Pretoria; Ohio State University; D. Warren Brown Family Foundation; Leukemia and Lymphoma Society","keywords":"Fludarabine; Rituximab; Medicine; Internal medicine; Chronic lymphocytic leukemia; Oncology; Leukemia; Surgery; Chemotherapy; Lymphoma; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004377413,0.0003651249,0.001451317,0.0006428065,0.00006761049,0.00002341109,0.0001910738,0.0002010708,0.00005808189],"category_scores_gemma":[0.0001603472,0.0002867627,0.0000778647,0.001682734,0.0004135346,0.0002109142,0.0001857248,0.0002642813,0.000001900991],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01586648,"about_ca_system_score_gemma":0.006414172,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006336134,"about_ca_topic_score_gemma":0.005206979,"domain_scores_codex":[0.9968052,0.0002101587,0.0006623557,0.0007564855,0.001013021,0.0005527691],"domain_scores_gemma":[0.9979692,0.0000963871,0.0002863857,0.0006997027,0.0006034367,0.0003448497],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01923085,0.008001764,0.9499633,0.001155447,0.007038416,0.0004415494,0.005892092,0.003373777,0.002976386,0.0007030879,0.00006723675,0.001156078],"study_design_scores_gemma":[0.1604648,0.005918853,0.8203126,0.00058542,0.002007808,0.00002302489,0.000153526,0.004167995,0.006005715,0.00005246705,0.000003463888,0.0003043136],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971381,0.0003004819,0.00002333831,0.00003600129,0.00002120278,0.00196575,0.000306646,0.00004514022,0.000163357],"genre_scores_gemma":[0.9982571,0.00003773211,0.0006100383,0.00001215843,0.00003043965,0.00007735883,0.0009200021,0.00003284328,0.00002233542],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.141234,"threshold_uncertainty_score":0.9999585,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0119435218848345,"score_gpt":0.2820362234149799,"score_spread":0.2700927015301454,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}